Literature DB >> 19416832

Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge.

Qiyun Zhu1, Vladimir G Zarnitsyn, Ling Ye, Zhiyuan Wen, Yulong Gao, Lei Pan, Ioanna Skountzou, Harvinder S Gill, Mark R Prausnitz, Chinglai Yang, Richard W Compans.   

Abstract

Influenza prophylaxis would benefit from a simple method to administer influenza vaccine into skin without the need for hypodermic needles. In this study, solid metal microneedle arrays (MNs) were investigated as a system for cutaneous vaccine delivery using influenza virus antigen. The MNs with 5 monument-shaped microneedles per array were produced and coated with inactivated influenza virus A/PR/8/34 (IIV). As much as 10 microg of viral proteins could be coated onto an array of 5 microneedles, and the coated IIV was delivered into skin at high efficiency within minutes. The coated MNs were used to immunize mice in comparison with conventional intramuscular injection at the same dose. Analysis of immune responses showed that a single immunization with IIV-coated MNs induced strong antibody responses against influenza virus, with significant levels of hemagglutination inhibition activities (>1:40), which were comparable to those induced by conventional intramuscular immunization. Moreover, mice immunized by a single dose of IIV coated on MNs were effectively protected against lethal challenge by a high dose of mouse-adapted influenza virus A/PR/8/34. These results show that MNs are highly effective as a simple method of vaccine delivery to elicit protective immune responses against virus infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416832      PMCID: PMC2683119          DOI: 10.1073/pnas.0812652106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults.

Authors:  Robert B Belshe; Frances K Newman; Ken Wilkins; Irene L Graham; Elizabeth Babusis; Marian Ewell; Sharon E Frey
Journal:  Vaccine       Date:  2007-07-26       Impact factor: 3.641

2.  Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.

Authors:  Pierre Van Damme; Froukje Oosterhuis-Kafeja; Marie Van der Wielen; Yotam Almagor; Ofer Sharon; Yotam Levin
Journal:  Vaccine       Date:  2008-11-18       Impact factor: 3.641

3.  Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing.

Authors:  J L K Wee; J-P Y Scheerlinck; K J Snibson; S Edwards; M Pearse; C Quinn; P Sutton
Journal:  Mucosal Immunol       Date:  2008-09-24       Impact factor: 7.313

4.  Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.

Authors:  David Holland; Robert Booy; Ferdinandus De Looze; Peter Eizenberg; James McDonald; Jeff Karrasch; Maureen McKeirnan; Hatem Salem; Graham Mills; Jim Reid; Françoise Weber; Melanie Saville
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

5.  Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus.

Authors:  Z Sha; R W Compans
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 6.  Transdermal drug delivery.

Authors:  Mark R Prausnitz; Robert Langer
Journal:  Nat Biotechnol       Date:  2008-11       Impact factor: 54.908

7.  Protection against lethal challenge by Ebola virus-like particles produced in insect cells.

Authors:  Yuliang Sun; Ricardo Carrion; Ling Ye; Zhiyuan Wen; Young-Tae Ro; Kathleen Brasky; Anysha E Ticer; E Ellen Schwegler; Jean L Patterson; Richard W Compans; Chinglai Yang
Journal:  Virology       Date:  2008-11-04       Impact factor: 3.616

8.  Effect of microneedle design on pain in human volunteers.

Authors:  Harvinder S Gill; Donald D Denson; Brett A Burris; Mark R Prausnitz
Journal:  Clin J Pain       Date:  2008-09       Impact factor: 3.442

9.  Microneedles permit transdermal delivery of a skin-impermeant medication to humans.

Authors:  Daniel P Wermeling; Stan L Banks; David A Hudson; Harvinder S Gill; Jyoti Gupta; Mark R Prausnitz; Audra L Stinchcomb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

10.  Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection.

Authors:  T M Tumpey; M Renshaw; J D Clements; J M Katz
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

View more
  70 in total

1.  Bacillus Calmette-Guérin vaccination using a microneedle patch.

Authors:  Yasuhiro Hiraishi; Subhadra Nandakumar; Seong-O Choi; Jeong Woo Lee; Yeu-Chun Kim; James E Posey; Suraj B Sable; Mark R Prausnitz
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

2.  DNA vaccination in the skin using microneedles improves protection against influenza.

Authors:  Jae-Min Song; Yeu-Chun Kim; Eunju O; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  Mol Ther       Date:  2012-04-17       Impact factor: 11.454

3.  Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.

Authors:  William C Weldon; Maria P Martin; Vladimir Zarnitsyn; Baozhong Wang; Dimitrios Koutsonanos; Ioanna Skountzou; Mark R Prausnitz; Richard W Compans
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

Review 4.  Skin permeabilization for transdermal drug delivery: recent advances and future prospects.

Authors:  Carl M Schoellhammer; Daniel Blankschtein; Robert Langer
Journal:  Expert Opin Drug Deliv       Date:  2014-01-07       Impact factor: 6.648

5.  Separable arrowhead microneedles.

Authors:  Leonard Y Chu; Mark R Prausnitz
Journal:  J Control Release       Date:  2010-11-01       Impact factor: 9.776

Review 6.  Polymeric microneedles for transdermal protein delivery.

Authors:  Yanqi Ye; Jicheng Yu; Di Wen; Anna R Kahkoska; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

Review 7.  Cutaneous immunization: an evolving paradigm in influenza vaccines.

Authors:  Harvinder S Gill; Sang-Moo Kang; Fu-Shi Quan; Richard W Compans
Journal:  Expert Opin Drug Deliv       Date:  2014-02-12       Impact factor: 6.648

8.  An electrically active microneedle array for electroporation.

Authors:  Seong-O Choi; Yeu Chun Kim; Jung-Hwan Park; Joshua Hutcheson; Harvinder S Gill; Yong-Kyu Yoon; Mark R Prausnitz; Mark G Allen
Journal:  Biomed Microdevices       Date:  2010-04       Impact factor: 2.838

9.  Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Dae-Goon Yoo; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

10.  Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.

Authors:  Zhiyuan Wen; Ling Ye; Yulong Gao; Lei Pan; Ke Dong; Zhigao Bu; Richard W Compans; Chinglai Yang
Journal:  Antiviral Res       Date:  2009-09-20       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.